M

Medicinova
D

MNOV

2.01000
USD
0.08
(4.15%)
Market Closed
Volume
0
EPS
-0
Div Yield
-
P/E
-13
Market Cap
98,582,954
Related Instruments
    A
    ARWR
    -2.890
    (-13.49%)
    18.540 USD
    B
    BNTC
    0.130
    (1.25%)
    10.500 USD
    C
    CRVS
    -0.31000
    (-3.64%)
    8.21000 USD
    N
    NVAX
    0.12000
    (1.67%)
    7.32500 USD
    T
    TRVN
    -2.02000
    (-44.99%)
    2.47000 USD
    V
    VKTX
    -3.960
    (-7.39%)
    49.620 USD
    More
News

Title: Medicinova

Sector: Healthcare
Industry: Biotechnology
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.